SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001193125-23-157987
Filing Date
2023-05-31
Accepted
2023-05-31 17:19:57
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 57231
2 GRAPHIC g472993dsp5.jpg GRAPHIC 5923
  Complete submission text file 0001193125-23-157987.txt   66540
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)